Trademark: 88604108
Word
IT'IS FOUNDATION
Status
Registered
Status Code
700
Status Date
Tuesday, May 11, 2021
Serial Number
88604108
Registration Number
6344495
Registration Date
Tuesday, May 11, 2021
Mark Type
4000
Filing Date
Wednesday, September 4, 2019
Published for Opposition
Tuesday, February 23, 2021

Trademark Owner History

Classifications
42 Research and development of health-related effects of electromagnetic energy in the fields of health, information technologies and emerging technologies; risk assessment consultation of safety and health risks, namely, prediction and assessment of health risks to human beings when exposed to electromagnetic fields, as well as prediction and assessment of the safety and efficacy of medical implants and the of the use of therapeutic and diagnostic medical devices on living organisms, and assessment of the efficacy of active and passive medical implants and therapeutic and diagnostic medical devices in treating medical conditions in humans; engineering design services and product compliance assessment in the nature of testing, analysis and evaluation of goods to determine conformity with certification standards; design and development of functionalized human and animal models, namely, design and development of computational anatomical models for biomedical modelling and safety assessment, as well as their functionalization with electrophysiology models, perfusion models, thermoregulation models, tissue models, and the personalization of such anatomical models for treatment simulation; design and development of functionalized human and animal models, namely, non-downloadable computational digital anatomical models for biomedical modelling; safety assessment in the nature of product safety testing; design and development of neuron models, dynamic and heterogeneous tissue models and personalized treatment simulation tools; MRI implant safety assessment in the nature of product safety testing evaluations of passive and active implants for patients undergoing magnetic resonance imaging scans, and providing customized solutions for mitigation of patient risk from radio frequency and gradient fields; MRI implant safety assessment services, namely, computational modelling and design of neuronal stimulation configurations and safety and efficacy optimization for the development and application of active implantable medical devices and electroceuticals; MRI safety testing and test systems, namely, customized product quality evaluations of radiofrequency and gradient field exposure for patients undergoing MRI scans; experimental phantoms, namely, development of phantom products and designs of new phantom technologies, development of physical multi-layer phantoms for evaluation of over the air device performance, specific absorption rate (SAR) and temperature rise, and for the optimization of on-body and implanted transceivers; electromagnetic fields (EMF) exposure systems, namely, design and development of customized exposure systems for in vitro, in vivo, and human studies on interactions of electromagnetic fields with living tissue; development of effective and selective neurostimulation solutions for research and industry for in silico, in vitro, in vivo, and human studies and applied research on interactions of electromagnetic fields with living tissue and therapeutic or diagnostic applications thereof; MRI safety phantom development for new technologies for implantable devices and medical implants; radio communication safety evaluation, namely, technical support services in the nature of troubleshooting of problems with radio communication platform development from device design to regulatory approval, and also for testing, analysis and evaluation of radio communication platforms to assure compliance with industry standards and to extend standardized procedures to other platforms, validating modifications with simulations and measurements, and communicating the changes to regulators; assessment of specific absorption rate exposure, namely, health risk assessment of voluntary and involuntary electromagnetic fields exposure ranging from the static to the terahertz frequencies, in the nature of prediction and assessment of health risks to the general public for research, industry and for public and private agencies; wireless power transfer assessment, namely, development and testing of dosimetric probes and testing, analysis and evaluation of the dosimetric probes to assure compliance of wireless power transfer (WPT) technologies with safety guidelines and industry standards; design and development of in- and on-body antennas, namely, design of electrically small, resonant and non-resonant antennas with optimized link budgets in complex environments, and also designing considering anatomical variability and current safety regulations; precision medicine applications, namely, design of radio frequency applicators and ultrasonic transducers for therapeutic applications; Technical support services, namely, data processing in the nature of analysis and segmentation of patient image data to generate personalised anatomical models for treatment planning, life sciences simulations, or in silico clinical trials; Technical support services, namely, data acquisition and/or evaluation in the nature of characterization of incident fields, namely, determining electromagnetic and/or acoustic exposure to assess safety and efficacy of voluntary or involuntary exposure to electromagnetic, acoustic, fluid dynamic, and mechanical fields and forces and for electromagnetic compatibility assessment; Technical support services, namely, data acquisition and/or analysis in the nature of focusing and tuning the effects of electromagnetic and/or acoustic exposure, namely, targeting localized electromagnetic and/or acoustic exposure and assessing shape of the overall distribution of the exposure and its biological impact; Technical support services, namely, computer modelling, analysis and evaluation of the treatment effects, namely, medical image-based modelling to generate realistic anatomical models for computational life sciences simulations, treatment modeling and treatment planning, and computational prediction of resulting biological and therapeutic effects; computational life sciences, namely, support services in virtual testing of diverse medical diagnostic and therapeutic applications using multi-scale and multi-physics computer simulations, medical image-based modeling, simulation platform and solver development; computational life sciences, namely, device safety testing and efficacy evaluation, namely, technical support service in the nature of testing and evaluation to improve performance safety and efficacy of therapeutic and diagnostic medical devices, body-worn devices, power transfer devices, and telecommunication equipment; computational life sciences, namely, scientific investigation to develop mechanistic understanding of biological and physiological responses to physical exposure of living organisms and tissues to electromagnetic, acoustic, fluid dynamic, and mechanical fields and forces for scientific research purposes; computational life sciences, namely, dielectric characteristics evaluation of the properties of tissue and other material samples by taking measurements to determine the dielectric characterization properties of tissue and other material samples for scientific research purposes and to provide modeling parameters for computational life sciences support services as specified above
45 regulatory compliance consulting in the field of safety, health, information technologies and emerging technologies; supporting regulatory approval of novel technologies, in the nature of obtaining regulatory permits, licenses and approvals to build electromagnetic fields technologies
"FOUNDATION"
IT IS FOUNDATION

Trademark Events
May 11, 2021
Registered-Principal Register
Feb 23, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 23, 2021
Published For Opposition
Feb 3, 2021
Notification Of Notice Of Publication E-Mailed
Jan 19, 2021
Approved For Pub - Principal Register
Jan 19, 2021
Examiner's Amendment Entered
Jan 19, 2021
Notification Of Examiners Amendment E-Mailed
Jan 19, 2021
Examiners Amendment E-Mailed
Jan 19, 2021
Examiners Amendment -Written
Jul 17, 2020
Notification Of Final Refusal Emailed
Jul 17, 2020
Final Refusal E-Mailed
Jul 17, 2020
Final Refusal Written
Jun 17, 2020
Teas/Email Correspondence Entered
Jun 17, 2020
Correspondence Received In Law Office
Jun 17, 2020
Teas Response To Office Action Received
Apr 27, 2020
Assigned To Lie
Apr 21, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 21, 2020
Teas Change Of Correspondence Received
Apr 21, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 21, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 21, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 21, 2020
Teas Change Of Owner Address Received
Dec 17, 2019
Notification Of Non-Final Action E-Mailed
Dec 17, 2019
Non-Final Action E-Mailed
Dec 17, 2019
Non-Final Action Written
Dec 6, 2019
Assigned To Examiner
Sep 16, 2019
New Application Office Supplied Data Entered In Tram
Sep 7, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24